Skip to main content
ConductScienceScienceDex
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

1,994

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

1,994 results for “Mortality;”

Learn how ShareScore rates datasets ↗
geo12/100

THC prevents mortality from ARDS through induction of immune cell apoptosis

GEO Series GSE153599. Mus musculus. 2 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJan 2021View details →
geo12/100

SET-9 and SET-26 impact transgenerational epigenetic inheritance and germline mortality through their PHD finger and SET domains [RNA-Seq ]

GEO Series GSE245980. Caenorhabditis elegans. 8 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenDec 2024View details →
geo12/100

Transcriptional memory of dFOXO activity in early adulthood delays late life mortality [RNA-seq]

GEO Series GSE183541. Drosophila melanogaster. 35 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenOct 2022View details →
geo12/100

Diarrhea as a Cause of Mortality in a Mouse Model of Infectious Colitis

GEO Series GSE8025. Mus musculus. 21 samples. Type: Expression profiling by array.

openGEO-OpenDec 2007View details →
geo12/100

SET-9 and SET-26 impact transgenerational epigenetic inheritance and germline mortality through their PHD finger and SET domains

GEO Series GSE245982. Caenorhabditis elegans. 16 samples. Type: Expression profiling by high throughput sequencing; Non-coding RNA profiling by high throughput sequencing.

openGEO-OpenDec 2024View details →
geo12/100

Whole blood transcriptomic profiling identifies expression signatures for sepsis mortality

GEO Series GSE272769. Homo sapiens. 161 samples. Type: Expression profiling by array.

openGEO-OpenNov 2025View details →
CCDI Data Catalog12/100

Cancer Incidence and Mortality in Massachusetts 2017-2021

The Massachusetts Cancer Registry (MACR) Incidence and Mortality Statewide Report 2017-2021 presents a summary of cancer incidence (new cases) and mortality (deaths) for the Commonwealth of Massachusetts. Specifically, the report provides cancer data by age, sex, racial ethnic group, and stage at diagnosis, highlighting recent trends (indicating annual percent change or APC) in Massachusetts cancer rates. The report also compares Massachusetts incidence and mortality rates to US rates. The collection and analysis of population-based cancer data help describe the burden of cancer in Massachusetts.

unknownView details →
CCDI Data Catalog12/100

2022 Cancer Incidence and Mortality in North Carolina

The contents of the 2022 Cancer Incidence and Mortality in North Carolina annual report represent a summary of the information collected on cancer diagnoses and deaths in 2022. The information includes incidence, and mortality counts and rates for all cancers by county, race, gender, and age. The primary goal of this report is to provide cancer data to healthcare planners, researchers, and the general public. The numbers reported here are for patients under the age of 44.

unknownView details →
CCDI Data Catalog12/100

Cancer in Utah: Incidence and Mortality Statistics through 2021

In this report, we provide updated cancer statistics for the state of Utah through 2021, the most recent year available for complete analysis. We summarize the number of new cancer diagnoses and deaths for 2021 and age-adjusted incidence and mortality rates for the period 2017-2021. We also present five-year relative survival estimates for the 2020 period, the most recent year available.

unknownView details →
zenodo12/100

Dataset related to the article "Cardiac surgeon and electrophysiologist shoulder-to-shoulder approach: Hybrid room, a kingdom for two. A zero mortality transvenous lead extraction single center experience"

<p>This record contains raw data related to the article &quot;Cardiac&nbsp;surgeon&nbsp;and&nbsp;electrophysiologist&nbsp;shoulder-to-shoulder&nbsp;approach:&nbsp;Hybrid&nbsp;room, a&nbsp;kingdom&nbsp;for&nbsp;two. A&nbsp;zero&nbsp;mortality&nbsp;transvenous&nbsp;lead&nbsp;extraction&nbsp;single&nbsp;center&nbsp;experience&quot;</p> <p>&nbsp;</p> <p>ABSTRACT</p> <p>BACKGROUND:</p> <p>Nowadays,&nbsp;transvenous&nbsp;lead&nbsp;extraction&nbsp;(TLE) is considered an essential technique in&nbsp;lead&nbsp;management strategy. Since 2011, a multidisciplinary&nbsp;approach&nbsp;was undertaken in our centre involving electrophysiologists,&nbsp;cardiac&nbsp;surgeons and anaesthesiologists to improve cross- unit cooperation and minimize complications and&nbsp;mortality. The present paper reports procedural outcomes and complications of our&nbsp;lead&nbsp;extraction&nbsp;experience.</p> <p>METHODS:</p> <p>We retrospectively collected and analysed data from all consecutive patients undergoing&nbsp;cardiac&nbsp;implantable electronic device leads TLE at the IRCCS Centro Cardiologico Monzino between January 2011 and November 2017.</p> <p>RESULTS:</p> <p>One-hundred fifty patients (111 males, 68 &plusmn; 13 years) underwent&nbsp;extraction&nbsp;procedures. The most common&nbsp;extraction&nbsp;indication were infections (86.7%) and TLE was carried out by laser-based&nbsp;approach&nbsp;in 88 (58.6%) patients, by mechanical dilating sheaths in 58 (38.7%) patients and by a combined&nbsp;approach&nbsp;(TLE + open surgical intervention) in 4 (2.7%) patients. Procedural success was obtained in 146 (97.3%) cases with only 3 (2.0%) major complications with 2 cases of structural injury with tamponade requiring emergent median sternotomy. Open surgery&nbsp;extraction&nbsp;was required in 4 patients, after an attempt to TLE, due to leads strict adhesion to&nbsp;cardiac&nbsp;or vascular structures, whereas in 5 (3.3%) cases, the treatment of choice was a combined&nbsp;approach&nbsp;consisting in&nbsp;transvenous&nbsp;leads&nbsp;extraction&nbsp;followed by planned surgery.</p> <p>CONCLUSIONS:</p> <p>TLE is a complex procedure that sometimes leads to fatal complications. In our&nbsp;single&nbsp;center&nbsp;experience, a multidisciplinary&nbsp;approach&nbsp;involving&nbsp;electrophysiologist,&nbsp;cardiac&nbsp;surgeon, anaesthesiologist in an operating&nbsp;room&nbsp;allows a safer&nbsp;approach&nbsp;and major complications treatment.</p>

restrictedMay 2020View details →
zenodo12/100

Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests

<p><strong>Introduction: </strong> The COVID-19 pandemic caused an increased mortality in nursing homes due to its quick spread and the age-related high lethality.</p> <p><strong>Results: </strong> We observed a two-month mortality of 40%, compared to 6.4% in the previous year. This increase was seen in both COVID-19 positive (43%) and negative (24%) residents, but 8 patients among those testing negative on the swab, tested positive on serological tests. Increased mortality was associated with male gender, older age, no previous vitamin D supplementation and worse &quot;activities of daily living (ADL)&quot; scores, such as Barthel index, Tinetti scale and S.OS.I.A.</p> <p><strong>Conclusion: </strong> Our data confirms a higher geriatric mortality due to COVID-19. Negative residents also had higher mortality, which we suspect is secondary to preanalytical error and a low sensitivity of the swab test in poorly compliant subjects. Male gender, older age and low scores on ADL scales (probably due to immobility) are risk factors for COVID-19 related mortality. Finally, mortality was inversely associated with vitamin D supplementation.</p> <p><strong>Design: </strong> In this observational study, we described the two-month mortality among the 157 residents (age 60-100) of a nursing home after Sars-CoV-2 spreading, reporting the factors associated with the outcome. We also compared the diagnostic tests for Sars-CoV-2.</p> <p>&nbsp; </p><p>https://pubmed.ncbi.nlm.nih.gov/33353888/</p> <p></p>

restrictedFeb 2021View details →
zenodo12/100

Mortality Datasets for Brazil from 2016 to 2022

Open the record for dataset details and reuse information.

embargoedcc-by-4.0Dec 2023View details →
zenodo12/100

Data Set_Urinary Albumin-to-Creatinine Ratio as an Independent Predictor of Long-term Mortality in Atherosclerotic Cardiovascular Disease Patients: A Propensity Score-Matched Study

Open the record for dataset details and reuse information.

restrictedcc-by-4.0Nov 2024View details →
zenodo12/100

Disability and mortality in a cohort of MS patients: how the real-world scenario is changed

<p>Demographical (sex and age) and clinical findings (functional system involved at MS onset, MS type, MS disability evaluated via EDSS scale, time to MS progression and use of disease modifying treatment) collected in a cohort of 86 patients with MS and with first hospitalization at IRCCS Mondino, Pavia (italy) in 2005-2006 and followed until 2018.&nbsp;</p>

restrictedOct 2021View details →
zenodo12/100

Method for antifragile and sustainable pest control by innovative device imposing one or more physical mortality factor(s)

<p>Method for antifragile and sustainable pest or weed control by innovative device imposing one or more physical mortality factor(s)</p> <p>Here we consider a mechanical device generating an airstream with a proper shape, fast enough and with a mass proper to cause the impairment on the target organism(s) and eventually the death of the organism by direct or indirect action.</p> <p>The stream will act on:</p> <ol> <li>the organism biotope to impair or destroy it;</li> <li>the organism biocoenosis to impair or destroy it;</li> <li>all the organism niche&nbsp;to impairing or destroy it;</li> <li>the organism itself, dislodging it from its niche enough to cause its impairment and eventually the death by direct or indirect action;</li> <li>the organism itself, directly injuring it&nbsp;and causing&nbsp;its impairment and the death by indirect action,&nbsp;ultimately;</li> <li>the organism itself, directly injuring it and causing&nbsp;its impairment and the death by direct action,&nbsp;ultimately;</li> <li>the organism itself, killing it by immediate action;</li> </ol> <p>The mechanical device will have an engine capable of moving a bladed device in the form of a turbine, a propeller, or other to force a proper air mass with an appropriate speed to produce a thrust effective for&nbsp;the&nbsp;use.</p> <p>One or more nozzle(s) will direct one or more air streams to the target pest.</p> <p>Purely mechanical to fully digital IoT systems and technologies can control the&nbsp;device.</p> <p>The mechanical device may have adds-on allowing the distribution of substances to enhance or adapt the thrust for the expected efficacy or the efficacy of the pest or weed control.</p>

restrictedJan 2022View details →
zenodo12/100

Aortic valve sclerosis as an important predictor of long-term mortality in patients with carotid atheromatous plaque requiring carotid endarterectomy

<p>This record contains raw data related to the article &quot;Aortic valve sclerosis as an important predictor of long-term mortality in patients with carotid atheromatous plaque requiring carotid endarterectomy&quot;.&nbsp;A strong association between aortic valve sclerosis (AVSc), the earliest manifestation of calcific aortic valve disease, and atherosclerosis exists. The aim of the study was to evaluate the predictive capabilities of AVSc on long-term all-cause mortality, in patients requiring carotid endarterectomy (CEA).&nbsp;806 consecutive CEA patients were enrolled. Preoperative echocardiography was used to assess AVSc. Computed tomography angiography was applied for plaque characterization. Kaplan-Meier curves, Cox linear regression, and area under the receiving operator characteristic (AUC) curve analyses were used to evaluate the predictive capability of AVSc. Overall, 348 of 541 patients had AVSc (64%). Age, diabetes, and estimated glomerular filtration rate (eGFR) were associated with AVSc. In the 5-year follow-up, AVSc group had a mortality rate of 16.7% while in no-AVSc group was 7.8%. Independent predictors of all-cause mortality were age, sex, eGFR, left ventricular ejection fraction, and AVSc. After adjustments, AVSc was associated with a significant increase in all-cause mortality risk (hazard ratio, HR = 1.9; 95%CI: 1.04-3.54;&nbsp;<em>p</em>&nbsp;= 0.038). We stratify our cohort based on carotid atheromatous plaque-type: soft, calcified, and mixed-fibrotic. In patients with mixed-fibrotic plaques, the mortality rate of AVSc patients was 15.5% compared to 2.4% in no-AVSc patients. In this group, AVSc was associated with an increased long-term all-cause mortality risk with an adjusted HR of 12.8 (95%CI: 1.71-96.35;&nbsp;<em>p</em>&nbsp;= 0.013), and the AUC, combing eGFR and AVSc was 0.77 (<em>p</em>&nbsp;&lt; 0.001).&nbsp;Our findings indicate that AVSc together with eGFR may be used to improve long-term risk stratification of patients undergoing CEA surgery.</p>

restrictedFeb 2022View details →
zenodo12/100

Machine Learning to Predict In-Hospital Mortality in COVID-19 Patients Using Computed Tomography-Derived Pulmonary and Vascular Features

<p>Dataset from&nbsp;Schiaffino S, Codari M, Cozzi A, Albano D, Al&igrave; M, Arioli R, Avola E, Bn&agrave; C, Cariati M, Carriero S, Cressoni M, Danna PSC, Della Pepa G, Di Leo G, Dolci F, Falaschi Z, Flor N, Fo&agrave; RA, Gitto S, Leati G, Magni V, Malavazos AE, Mauri G, Messina C, Monfardini L, Pasch&egrave; A, Pesapane F, Sconfienza LM, Secchi F, Segalini E, Spinazzola A, Tombini V, Tresoldi S, Vanzulli A, Vicentin I, Zagaria D, Fleischmann D, Sardanelli F. Machine Learning to Predict In-Hospital Mortality in COVID-19 Patients Using Computed Tomography-Derived Pulmonary and Vascular Features. J Pers Med. 2021 Jun 3;11(6):501. doi: 10.3390/jpm11060501. PMID: 34204911; PMCID: PMC8230339.</p> <p>Abstract</p> <p>Pulmonary parenchymal and vascular damage are frequently reported in COVID-19 patients and can be assessed with unenhanced chest computed tomography (CT), widely used as a triaging exam. Integrating clinical data, chest CT features, and CT-derived vascular metrics, we aimed to build a predictive model of in-hospital mortality using univariate analysis (Mann-Whitney&nbsp;<em>U</em>&nbsp;test) and machine learning models (support vectors machines (SVM) and multilayer perceptrons (MLP)). Patients with RT-PCR-confirmed SARS-CoV-2 infection and unenhanced chest CT performed on emergency department admission were included after retrieving their outcome (discharge or death), with an 85/15% training/test dataset split. Out of 897 patients, the 229 (26%) patients who died during hospitalization had higher median pulmonary artery diameter (29.0 mm) than patients who survived (27.0 mm,&nbsp;<em>p</em>&nbsp;&lt; 0.001) and higher median ascending aortic diameter (36.6 mm versus 34.0 mm,&nbsp;<em>p</em>&nbsp;&lt; 0.001). SVM and MLP best models considered the same ten input features, yielding a 0.747 (precision 0.522, recall 0.800) and 0.844 (precision 0.680, recall 0.567) area under the curve, respectively. In this model integrating clinical and radiological data, pulmonary artery diameter was the third most important predictor after age and parenchymal involvement extent, contributing to reliable in-hospital mortality prediction, highlighting the value of vascular metrics in improving patient stratification.</p>

restrictedFeb 2022View details →
zenodo12/100

Raw Data_Inflammation-based Glasgow Prognostic Score level and mortality in patients with cardiovascular disease: the National and Health Nutrition Examination Survey 1999-2010

<p>The raw&nbsp;data supporting the results of this study (Inflammation-based Glasgow Prognostic Score level and mortality in patients with cardiovascular disease: the National and Health Nutrition Examination Survey 1999-2010)</p>

restrictedOct 2022View details →
zenodo12/100

Data set for "Hemoglobin, albumin, lymphocyte, and platelet score: A risk prediction tool for incidence and mortality in diabetic kidney disease patients with type 2 diabetes "

Open the record for dataset details and reuse information.

restrictedcc-by-4.0Oct 2024View details →
zenodo12/100

Dataset related to article "EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide

<p>This record contains raw data related to article &ldquo;EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide&quot;</p> <p>Endothelial Activation and Stress Index (EASIX) is a prognostic score reflecting endothelial damage. It can identify cohorts of patients at higher risk of non-relapse mortality (NRM) after allogeneic stem cell transplantation (SCT) from a matched-related or -unrelated donor. No data are available in the setting of haploidentical-SCT with post-transplant cyclophosphamide (PT-Cy). We retrospectively analyzed the role of EASIX score in a cohort of 266 patients receiving Haplo-SCT with PT-Cy at our center. By a decision-tree model, 1-year NRM was 16% vs. 29% and overall survival was 59% vs. 32%, respectively, for patients with a pre-transplant EASIX (EASIX-PRE) &lt;0.8 vs. &ge;0.8 (p &lt; 0.001). By multivariable analysis, EASIX-PRE was an independent predictor of NRM (hazard ratio [HR] 2.43, p &lt; 0.001) and overall survival (HR: 1.64, p = 0.011). EASIX-PRE did not predict patients at higher risk of developing acute graft-versus-host disease (GVHD) but was an independent predictor of 1-year NRM (3.2 cutoff, HR 6.61, p = 0.002; &lt;3.2 vs. &ge;3.2: 10% vs. 56%, p &lt; 0.001) in patients developing acute GVHD. EASIX score can also represent an important tool to predict mortality in the setting of Haplo-SCT with PT-Cy. It may help to make therapeutic decisions both before the transplant and at the onset of acute GVHD.</p>

restrictedFeb 2023View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.